Tudor Investment Corp’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,356
Closed -$2.44M 3458
2025
Q3
$2.44M Buy
51,356
+46,682
+999% +$2.26M 0.02% 1677
2025
Q2
$249K Sell
4,674
-40,327
-90% -$1.83M ﹤0.01% 2981
2025
Q1
$1.82M Buy
45,001
+10,207
+29% +$433K 0.02% 1414
2024
Q4
$968K Buy
34,794
+160
+0.5% +$4.85K 0.01% 1752
2024
Q3
$994K Buy
34,634
+315
+0.9% +$8.21K 0.01% 1622
2024
Q2
$805K Sell
34,319
-1,876
-5% -$40.1K 0.01% 1574
2024
Q1
$914K Buy
+36,195
New +$869K 0.01% 1375
2023
Q4
Sell
-31,881
Closed -$1.61M 2326
2023
Q3
$1.61M Buy
+31,881
New +$1.48M 0.02% 1042
2023
Q2
Sell
-36,885
Closed -$1.41M 2389
2023
Q1
$1.41M Buy
36,885
+13,887
+60% +$619K 0.03% 983
2022
Q4
$1.26M Buy
22,998
+10,852
+89% +$465K 0.03% 942
2022
Q3
$414K Buy
+12,146
New +$186K 0.01% 1537

Other funds holding AKRO